| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/18/2003 | US20030176372 Anti-virus agent |
| 09/18/2003 | US20030176355 Administering protein and biologically active substance; formulation acquires a non-liquid form under physiological conditions and biologically active substance is delivered from non-liquid to localized site |
| 09/18/2003 | US20030176354 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 09/18/2003 | US20030176352 Peptides and related compounds having thrombopoietic activity |
| 09/18/2003 | US20030176350 Method of inhibiting cell proliferation using an anti-oncogene protein |
| 09/18/2003 | US20030176349 Stable hypoxia inducible factor-1 alpha and method of use |
| 09/18/2003 | US20030176348 For use as therapeutic agent for a syndrome resembling premature aging, a therapeutic agent for adult diseases or an aging-suppressing agent |
| 09/18/2003 | US20030176344 Diagnosing a susceptibility to osteoporosis in an individual, comprising detecting at least one polymorphism in a human BMP2 gene |
| 09/18/2003 | US20030176343 Administering to the subject an amount of topors (protein) effective to inhibit the uncontrolled proliferation for therapy |
| 09/18/2003 | US20030176342 Novel potassium channel |
| 09/18/2003 | US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent |
| 09/18/2003 | US20030176340 For therapy of renal failure |
| 09/18/2003 | US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders |
| 09/18/2003 | US20030176337 Useful for inhibiting microbial infection or growth, as well reducing the effects of endotoxemia |
| 09/18/2003 | US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2003 | US20030176335 Surfactant peptide nanostructures, and uses thereof |
| 09/18/2003 | US20030176334 Using vitronectin alpha v beta 3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases |
| 09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
| 09/18/2003 | US20030176328 For producing medicament for therapy of type 1 diabetes; impaired glucose tolerance; type 2 diabetes; syndrome X; obesity; cardiovascular disease, such as atherosclerosis; septic shock; or dyslipidemia rheumatoid arthritis |
| 09/18/2003 | US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha |
| 09/18/2003 | US20030176315 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 09/18/2003 | US20030175996 Peptide fructose and complex thereof with binding protein |
| 09/18/2003 | US20030175995 Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 09/18/2003 | US20030175975 Using plasmid Dna; cyclic peptide |
| 09/18/2003 | US20030175974 Human gene therapy |
| 09/18/2003 | US20030175972 Cloning nucleic acids; virus vector |
| 09/18/2003 | US20030175962 Gene encoding b protein |
| 09/18/2003 | US20030175958 Methods for using bag expression as a cell differentiation agent and marker |
| 09/18/2003 | US20030175953 Immortalized vascular adventital cell line |
| 09/18/2003 | US20030175938 Antiinflammatory agents; autoimmune disease; anticancer agents; antitumor agents; wound healing agents |
| 09/18/2003 | US20030175936 Poly - gamma - glutamic acid decomposing enzyme gene and method for producing poly - gamma - glutamic acid |
| 09/18/2003 | US20030175930 Crystals of LuxP and complexes thereof |
| 09/18/2003 | US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/18/2003 | US20030175919 ITI-D1 Kunitz domain mutants as hNE inhibitors |
| 09/18/2003 | US20030175907 Method of constructing a synthetic polynucleotide |
| 09/18/2003 | US20030175904 Genetic engineering; antibody binding; transgenic animals |
| 09/18/2003 | US20030175900 Compositions and methods for the treatment of tumor |
| 09/18/2003 | US20030175898 Isolated nucleic acids; immune response disease |
| 09/18/2003 | US20030175897 Human interferon, Zinf2 |
| 09/18/2003 | US20030175895 Chemokine |
| 09/18/2003 | US20030175894 Chemokine alpha-6 |
| 09/18/2003 | US20030175893 Metabolism mutant; nucleic acid cassette |
| 09/18/2003 | US20030175891 Human orphan G protein-coupled receptors |
| 09/18/2003 | US20030175890 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor |
| 09/18/2003 | US20030175889 Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR |
| 09/18/2003 | US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use |
| 09/18/2003 | US20030175887 Saturation mutagenesis in directed evolution |
| 09/18/2003 | US20030175885 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/18/2003 | US20030175883 DNA encoding a mammalian LPA receptor and uses thereof |
| 09/18/2003 | US20030175882 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175881 Nucleic acids encoding (poly) peptides having chips activity |
| 09/18/2003 | US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment |
| 09/18/2003 | US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175864 Human FRP and fragments thereof including methods for using them |
| 09/18/2003 | US20030175863 Influenza immunogen and vaccine |
| 09/18/2003 | US20030175862 Engineered open reading frame for p53 |
| 09/18/2003 | US20030175860 Seleno-cysteine containing protein zsel1 |
| 09/18/2003 | US20030175859 Fluorescent proteins |
| 09/18/2003 | US20030175857 Of given sequence termed Con-218; constructs and recombinant host cells incorporating the genes; antibodies ; used as therapeutic target and to purify G-proteins |
| 09/18/2003 | US20030175856 Tumor necrosis factor receptor polypeptide (RTD) for use in treatmment of nervous system, liver, viral and reperfusion injuries/disorders |
| 09/18/2003 | US20030175855 Human sdf-5 protein and compositions |
| 09/18/2003 | US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 09/18/2003 | US20030175837 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 09/18/2003 | US20030175835 Gram-negative negative bacteria such as pasteurella trehalosi and/or mannheimia haemolytica for diagnosis and treatment of respiratory disorders in animals; veterinary medicine; genetic vaccines |
| 09/18/2003 | US20030175830 Reagents and methods for the screening of compounds useful in the treatment of neurological diseases |
| 09/18/2003 | US20030175825 Cytokine receptor zalpha11 |
| 09/18/2003 | US20030175822 Opiate, cannabinoid, and estrogen receptors |
| 09/18/2003 | US20030175809 Fluorescent timer proteins and methods for their use |
| 09/18/2003 | US20030175808 Novel protein and dna thereof |
| 09/18/2003 | US20030175807 Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level |
| 09/18/2003 | US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 09/18/2003 | US20030175801 Treating cancer via increase in expression of interferons and colony stimulating factors with concomitant decrease in transforming growth factor, prostaglandin and vascular endothelial growth factors expression in cells; immunoassays |
| 09/18/2003 | US20030175799 Comprises stable amino acid sequence scaffold which mimics native protein structures and interactions; drug screening and design |
| 09/18/2003 | US20030175796 Using oligonucleotide primers to screen and detect penicillin and vancomycin resistant streptococcus |
| 09/18/2003 | US20030175795 Polynucleotides associated with cardiac muscle function |
| 09/18/2003 | US20030175794 Compositions for isolating a cDNA encoding a membrane-bound protein |
| 09/18/2003 | US20030175792 Chemokine Alpha-4 |
| 09/18/2003 | US20030175787 Comprises nucleotide sequences coding transport protein for diagnosis and treatment of cell proliferative disorders such as cancer; animal models; antiproliferative agents |
| 09/18/2003 | US20030175778 Interferon Receptor HKAEF92 |
| 09/18/2003 | US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 09/18/2003 | US20030175770 Diagnosing cancer in animal and humans via screens which detect extracellular viral nucleotide sequences associated with cell proliferative disease |
| 09/18/2003 | US20030175767 Chemoreceptors in plant parasitic nematodes |
| 09/18/2003 | US20030175764 Monitoring interleukin allelic expression to detect occlusive, fragile plaque, restenosive and atherscerotic disorders |
| 09/18/2003 | US20030175762 Modulators on Nod2 signaling |
| 09/18/2003 | US20030175755 Diagnosing sensitivity to oral diseases via analysis of mutation in defensin nnuclelotide sequences and gene expression pattern |
| 09/18/2003 | US20030175754 Comprises rat ventral prostate protein-1 (RVP-1) for diagnosis and treatment of inflammatory bowel diseases |